T-Helper Cell-Response to MHC Class II-Binding Peptides of the Renal Cell Carcinoma-Associated Antigen RAGE-1

This publication has 32 references indexed in Scilit:

• Dendritic Cells in Cancer Immunotherapy
  Annual Review of Immunology, 2000
• Human melanoma therapy in the SCID mouse:In vivo targeting and reactivation of melanoma-specific cytotoxic T cells by bi-specific antibody fragments
  International Journal of Cancer, 1999
• Mature Dendritic Cells Induce T-Helper Type-1-Dominant Immune Responses in Patients with Metastatic Renal Cell Carcinoma
  Urologia Internationalis, 1999
• Specific T Helper Cell Requirement for Optimal Induction of Cytotoxic T Lymphocytes against Major Histocompatibility Complex Class II Negative Tumors
  The Journal of Experimental Medicine, 1998
• Origin, maturation and antigen presenting function of dendritic cells
  Current Opinion in Immunology, 1997
• The immune system
  Seminars in Oncology Nursing, 1996
• Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines.
  The Journal of Experimental Medicine, 1996
• A Comparison of 2 Modes of Administration of Recombinant Interleukin-2: Continuous Intravenous Infusion Alone Versus Subcutaneous Administration plus Interferon Alpha in Patients with Advanced Renal Cell Carcinoma.
  Cancer Biotherapy, 1993
• HLA‐DR typing by PCR amplification with sequence‐specific primers (PCR‐SSP) in 2 hours: An alternative to serological DR typing in clinical practice including donor‐recipient matching in cadaveric transplantation
  Tissue Antigens, 1992
• A Progress Report on the Treatment of 157 Patients with Advanced Cancer Using Lymphokine-Activated Killer Cells and Interleukin-2 or High-Dose Interleukin-2 Alone
  New England Journal of Medicine, 1987